Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022

SELL
$373.53 - $434.12 $11,205 - $13,023
-30 Closed
0 $0
Q3 2021

Nov 09, 2021

SELL
$396.76 - $455.92 $14,680 - $16,869
-37 Reduced 55.22%
30 $12,000
Q4 2020

Feb 02, 2021

SELL
$319.05 - $363.32 $6,700 - $7,629
-21 Reduced 23.86%
67 $24,000
Q2 2020

Jul 27, 2020

BUY
$270.93 - $320.3 $1,625 - $1,921
6 Added 7.32%
88 $25,000
Q1 2020

Apr 22, 2020

SELL
$243.44 - $359.98 $3,895 - $5,759
-16 Reduced 16.33%
82 $23,000
Q4 2019

Feb 03, 2020

BUY
$281.18 - $322.05 $25,306 - $28,984
90 Added 1125.0%
98 $31,000
Q3 2019

Nov 12, 2019

SELL
$294.25 - $341.49 $27,365 - $31,758
-93 Reduced 92.08%
8 $2,000
Q2 2019

Jul 12, 2019

BUY
$279.29 - $336.89 $28,208 - $34,025
101 New
101 $34,000

Others Institutions Holding COO

About COOPER COMPANIES, INC.


  • Ticker COO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 49,346,000
  • Market Cap $4.92B
  • Description
  • The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses corr...
More about COO
Track This Portfolio

Track Evolution Wealth Advisors, LLC Portfolio

Follow Evolution Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.